Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...

DM Clinical Research, a leading multi-therapeutic site network, today announced the formation of its inaugural Advisory Board. Comprising respected leaders from clinical research and healthcare, the ...

Jean-Claude Saghbini is the Chief Technology Officer and President of Lumeris Technology, driving Tom™ – Lumeris' AI-powered Primary Care as a Service platform, delivering scalable, coordinated, and ...

Today’s macro headwinds add pressure when asset managers are already competing in a crowded field. Market volatility, interest rates, and inflation are making rapid moves unlike anything the industry ...

Healthcare Business Intelligence Market OverviewThe global Healthcare Business Intelligence Market is valued at USD 10.05 Billion in 2024 and is projected to reach a value of USD 42.08 Billion by 2035 ...

As of October 2025, CMS has officially removed Section R from the Minimum Data Set (MDS), eliminating four items related to ...

Background Diabetes mellitus (DM) is a common comorbidity in hypertrophic cardiomyopathy (HCM) and may exacerbate arrhythmic ...

We came across a bullish thesis on Nuvation Bio Inc. on wallstreetbets subreddit by asagi_lumina. In this article, we will summarize the bulls’ thesis on NUVB.

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Mounjaro, originally developed as a diabetes drug, has skyrocketed to become India’s no. 2 pharma brand, thanks to a booming ...

Quick Suite helps you cut through the noise of fragmented information, siloed applications, and repetitive tasks to focus on what matters.

Almost three-quarters of people incarcerated in Irish prisons have some form of substance addiction – but face long waits for ...